Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Is the Pharma Industry Missing the Big Picture?

Posted on September 22nd, 2017 by in Pharma R&D

There is a disconnect between how drugs are developed and how they are used. In the traditional method of target-oriented development, each new candidate drug is scrutinized in a handful of interactions with desirable and undesirable targets. Continue reading “Is the Pharma Industry Missing the Big Picture?” »

Introducing e-Therapeutics: An In Silico Drug Discovery Lab

Posted on May 1st, 2017 by in Chemistry

When laypeople think of drug development, they almost certainly imagine clinical labs filled with chemistry and biology labware or trials with control and test groups receiving different doses of the proposed new treatments. Continue reading “Introducing e-Therapeutics: An In Silico Drug Discovery Lab” »

New Reaxys: A Model of Agile Development

Posted on April 11th, 2017 by in Chemistry

The development of a chemistry research solution is not something that should occur solely in the IT department of the product owner. Without the participation of the intended end users of the product, how can the developers be sure that they’re addressing real needs? Continue reading “New Reaxys: A Model of Agile Development” »

The Fundamentals of Good Data Stewardship

Posted on June 29th, 2016 by in Pharma R&D

Bioactivity data is not in short supply. The days of limited availability of data on compounds and biological targets are long behind us. Continue reading “The Fundamentals of Good Data Stewardship” »

  1. 1
  2. 2
  3. 3
  4. 4